Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

ClinicalTrials.gov ID: NCT00296374

Public ClinicalTrials.gov record NCT00296374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 2:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomised, Double-blind, 52-wk, Parallel-grp, Multicentre, PIIb Study to Evaluate Effects of Rosuvastatin 10mg, Rosuvastatin 40mg and Atorvastatin 80mg on Urinary Protein Excretion in Hypercholesterolaemic Diabetic Patients With Moderate Proteinuria

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

Study identification

NCT ID
NCT00296374
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
353 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Sep 1, 2011

2006 – 2009

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Research Site Avondale Arizona — —
Research Site Phoenix Arizona — —
Research Site Jonesboro Arkansas — —
Research Site Pasadena California — —
Research Site Riverside California — —
Research Site Santa Ana California — —
Research Site West Hills California — —
Research Site Hollywood Florida — —
Research Site Jacksonville Florida — —
Research Site West Palm Beach Florida — —
Research Site Augusta Georgia — —
Research Site Topeka Kansas — —
Research Site Springfield Massachusetts — —
Research Site Detroit Michigan — —
Research Site Columbia Missouri — —
Research Site St Louis Missouri — —
Research Site Orchard Park New York — —
Research Site Stony Brook New York — —
Research Site Winston-Salem North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Kettering Ohio — —
Research Site Pittsburgh Pennsylvania — —
Research Site Columbia South Carolina — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site Lubbock Texas — —
Research Site San Antonio Texas — —
Research Site Ogden Utah — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00296374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2011 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00296374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →